Skip to main content
Premium Trial:

Request an Annual Quote

Biogen Idec to Use Almac Technology to Extract Genetic Material from Samples

NEW YORK (GenomeWeb News) – Biogen Idec will use Almac Diagnostics’ expertise in extracting genetic information from formalin-fixed paraffin embedded tissue, Almac said yesterday.
 
Craigavon, Northern Ireland-based Almac said that Biogen Idec would use the process for SNP analysis in a phase II study of a drug for treating gastrointestinal stromal tumors. The firm’s process enables researchers to use FFPE samples in qPCR and microarray SNP genotyping and gene expression studies.
 
Julie Ranuio-Kelley, senior associate scientist at Cambridge, Mass.-based Biogen Idec, said that Almac’s technology would allow the firm to “uncover biomarkers that will help us discover additional drug candidates and identify specific patient populations that will benefit from a particular treatment.”